Li-Rong Yu
Role not yet determined Is this you? Add your title
Also affiliated: United States Food and Drug Administration (2024–2026)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Li-Rong Yu's research focuses on the molecular mechanisms underlying bacterial infections, particularly in the context of host-pathogen interactions and disease progression. Yu has investigated variations in *Campylobacter jejuni* strains, examining phenotypic, genotypic, and proteomic differences between those that colonize poorly versus robustly. This work has involved the application of advanced proteomic techniques to understand bacterial behavior and adaptation. Yu's research also extends to broader health science applications, including the identification of proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity and the role of microRNAs in protein networks associated with COVID-19 disease progression. Yu has collaborated with researchers at the National Center for Toxicological Research, including Saeed Khan, Kidon Sung, Miseon Park, and Ohgew Kweon, contributing to shared publications.
Metrics
- h-index: 1
- Publications: 3
- Citations: 1
Selected Publications
-
Integrated miR-omics and proteomics reveal the regulatory role of miR in protein networks associated with COVID-19 disease progression (2026)
-
Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients (2026)
-
Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains (2024)
Collaboration Network
Top Collaborators
- Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients
- Integrated miR-omics and proteomics reveal the regulatory role of miR in protein networks associated with COVID-19 disease progression
- Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains
- Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains
- Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains
- Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains
- Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains
- Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains
- Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains
- Phenotypic, genotypic and proteomic variations between poor and robust colonizing Campylobacter jejuni strains
- Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients
- Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients
- Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients
- Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients
- Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients
- Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients
Similar Researchers
Based on overlapping research topics